Radiation-induced Glioblastoma Multiforme in Children Treated for Medulloblastoma With Characteristics of Both Medulloblastoma and Glioblastoma Multiforme

Outcomes for average-risk medulloblastoma are excellent with 5-year event-free survival and overall survival>80%. Treatment failures include radiation-induced glioblastomas (RIG), which are often diagnosed solely on imaging. Recent studies suggest that RIGs differ from spontaneous glioblastoma multiforme (GBM), based on microarray gene-expression profiling. Retrospective review of children with average-risk medulloblastoma treated from 1996 to 2003 included 16 patients with 5 treatment failures. One died of disease progression, 1 died as a result of radiation necrosis, and 3 children died of pathology-confirmed GBM. Of these 3 GBMs, one was studied with electron microscopy, cytogenetics, and gene-expression microarray analysis. This tumor had focal medulloblastoma and similarity by gene-expression microarray with other RIGs. With both components in the recurrent tumor, we suggest it was in the process of transitioning from medulloblastoma to RIG, that is, “catching the tumor in the act.” Some radiation-induced nervous system tumors may develop as a direct result of severe oncologic changes within the original tumor cells, with the tumor evolving into a different phenotypic tumor type. We recommend biopsy for tissue confirmation and genetic expression profile to shed light on the etiology of radiation-induced neoplasms.

[1]  M. Chintagumpala,et al.  Radiation-induced malignant gliomas: is there a role for reirradiation? , 2008, International journal of radiation oncology, biology, physics.

[2]  D. Srivastava,et al.  High‐dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors , 2008, Cancer.

[3]  B. Kleinschmidt-DeMasters,et al.  Unique Molecular Characteristics of Radiation-Induced Glioblastoma , 2007, Journal of neuropathology and experimental neurology.

[4]  H. Koo,et al.  High‐dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high‐risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor , 2007, Pediatric blood & cancer.

[5]  D. Johnston,et al.  Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  P. Burger,et al.  Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Anwar,et al.  Paired Overexpression of ErbB3 and Sox10 in Pilocytic Astrocytoma , 2006, Journal of neuropathology and experimental neurology.

[8]  J. Buatti,et al.  Radiation induced adult medulloblastoma: a case report , 2006, Journal of Neuro-Oncology.

[9]  K. Lillehei,et al.  The Burden of Radiation-Induced Central Nervous System Tumors: A Single Institution s Experience , 2006, Journal of neuropathology and experimental neurology.

[10]  R. Schmidt,et al.  Cancer therapy-associated CNS neuropathology: an update and review of the literature , 2006, Acta Neuropathologica.

[11]  K. Wang,et al.  Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma: case report. , 2005, Journal of neurosurgery.

[12]  J. Ryu,et al.  Secondary supratentorial primitive neuroectodermal tumor following irradiation in a patient with low-grade astrocytoma. , 2005, AJNR. American journal of neuroradiology.

[13]  N. Çetingül,et al.  Radiotherapy-induced secondary cranial neoplasms in children , 2004, Child's Nervous System.

[14]  W. Hader,et al.  Primitive neuroectodermal tumors in the central nervous system following cranial irradiation , 2003, Cancer.

[15]  S. Nishio,et al.  Evolution of Malignant Cerebellar Astrocytoma at the Site of a Treated Medulloblastoma: Report of two Cases , 2001, Acta Neurochirurgica.

[16]  T. Tamiya,et al.  Malignant cerebellar astrocytoma developing 15 years after radiation therapy for a medulloblastoma , 1998, Clinical Neurology and Neurosurgery.

[17]  H. Woodard,et al.  Sarcoma arising in irradiated bone , 1998, Cancer.

[18]  S. Bertolone,et al.  Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Bliss,et al.  Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. , 1992, BMJ.

[20]  T. H. van der Kwast,et al.  Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas , 1990, Cancer.

[21]  H. Budka,et al.  Glioblastoma developing at the site of a cerebellar medulloblastoma treated 6 years earlier. Case report. , 1987, Journal of neurosurgery.

[22]  S. Mirra,et al.  Glioblastoma multiforme occurring 13 years after treatment of a medulloblastoma. , 1980, Neurosurgery.

[23]  S. Stein,et al.  Development of cerebellar malignant astrocytoma at site of a medulloblastoma treated 11 years earlier. Case report. , 1978, Journal of neurosurgery.